HMD — Hera Med Income Statement
0.000.00%
- AU$14.01m
- AU$11.04m
- AU$0.36m
Annual income statement for Hera Med, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | fx Final | Final | Final |
Revenue | |||||
Total Revenue | 0.057 | 0.115 | 0.316 | 0.606 | 0.364 |
Cost of Revenue | |||||
Gross Profit | 0.012 | 0.059 | 0.203 | 0.364 | 0.219 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4.94 | 5.49 | 4.9 | 7.28 | 5.82 |
Operating Profit | -4.89 | -5.38 | -4.59 | -6.67 | -5.45 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.88 | -7.61 | -7.04 | -6.78 | -5.49 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.88 | -7.61 | -7.04 | -6.78 | -5.49 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.88 | -7.61 | -7.04 | -6.78 | -5.49 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.88 | -7.61 | -7.04 | -6.78 | -5.49 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.038 | -0.041 | -0.032 | -0.025 | -0.01 |